Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel

Conventional treatment for advanced ovarian cancer is an initial debulking surgery followed by chemotherapy combination of carboplatin and paclitaxel. Despite initial high response, three-fourths of these women experience disease recurrence with a dismal prognosis. Patients with advanced-stage ovari...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomark Cancer
Autori principali: Sehrawat, Urmila, Pokhriyal, Ruchika, Gupta, Ashish Kumar, Hariprasad, Roopa, Khan, Mohd Imran, Gupta, Divya, Naru, Jasmine, Singh, Sundararajan Baskar, Mohanty, Ashok Kumar, Vanamail, Perumal, Kumar, Lalit, Kumar, Sunesh, Hariprasad, Gururao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Libertas Academica 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4795487/
https://ncbi.nlm.nih.gov/pubmed/26997873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BIC.S35775
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi